SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian Pastor who wrote (2033)6/17/1997 7:59:00 PM
From: Edderd   of 3991
 
Brian,
I'm not sure what you mean non-invasive. You do not break the skin but you do invade a natural orifice. We have many medications that are used by suppository absorption. Is that invasive? Muse is now the first treatment of choice for ED (erectile dysfunction). Note that this is not strictly impotence. Very important in understanding the huge market available. The Vivus rep was in the office and stated that they were backordered to December (80M). The new facilities are to be opened at that time. Doesn't look like a good time to be short. Who knows but the longer the fundamentals last the more likely we will not see the huge pullback of the "hyped 80's". Just my opinion. Tne patients are 50 to 70 % happy with the trial doses that we use (250 and 500), Refills are a littleless I think but we don't keep a record. The nurses say 75% but I'm skeptical. Its enough tho.
Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext